| CAS No.: | 2023788-19-2 |
|---|---|
| Formula: | C225h348n48o68 |
| EINECS: | / |
| Type: | / |
| Appearance: | White Powder |
| Quality: | Technical |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier Introduction :
What is tirzepatide?
Tirzepatide (Zepbound, jaro) is used for weight loss and type 2 diabetes in adults. Tirzepatide is a GIP and GLP-1 receptor agonist and works for weight loss by decreasing your appetite and slowing the movement of food from the stomach into the small intestine, which may make you feel full more quickly and for a longer period of time. Tirzepatide also decreases blood sugar levels by increasing inslin production and lowering the amount of sugar the liver makes.
Zepbound is FDA-approved for weight loss for adults with obesity or who are overweight and have weight-related medical problems. Zepbound helps you to lose weight and maintain weight loss and should be combined with diet and exercise.
njaro is used to help lower blood sugar for adults with type 2 diabetes; it should be used together with diet and exercise.
Mro and Zepbound both contain the same active ingredient, tirzepatide and are made by Eli Lilly and Company. They are both given as weekly injections under the skin and are available as single-dose pens in the same strengths 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg,15 mg per 0.5 mL.
| Product Name | High Quality Tirzepatide / GIP\GLP-1 CAS 2023788-19-2 |
| CAS NO. | 2023788-19-2 |
| Appearance | White Powder |
| Purity | 99% |
| Application | Small molecule inhibitor; Polypeptide |
| Usage | Tirzepatide often be used as small molecule inhibitor. |
Initial dose: 2.5 mg under the skin (subcutaneously) once a week.
After 4 weeks: The dosage should be increased to 5 mg subcutaneously once a week.
Further dose increases: After at least 4 weeks on the current dose the dosage may be increased in 2.5 mg increments.
Recommended maintenance dose: 5 mg, 10 mg, or 15 mg injected subcutaneously once weekly.
Maximum dose: 15 mg subcutaneously once a week.
Initial dose: 2.5 mg under the skin (subcutaneously) once a week.
After 4 weeks: The dosage should be increased to 5 mg subcutaneously once a week.
If additional glycemic control is needed: The dosage should be increased in 2.5 mg increments after at least 4 weeks on the current dose.
Maximum dose: 15 mg subcutaneously once a week.
Comments: The 2.5 mg dosage is for starting of treatment and is not intended for glycemic control. The day of weekly administration can be cha
What should I do if I miss a dose?
If you miss a dose of tirzepatide take the missed dose as soon as you remember it, if within 4 days after the missed dose. However, if it has been more than 4 days since your last dose, then skip the missed dose and continue your regular dosing schedule. Do not inject two doses within 3 days of each other.
| Goods weight |
Packing |
Shipping method |
Lead-time |
| 1-50kg |
Below 5kg Use Foil bag;5-25kg use two layer PP bag,then into master carton or cardboard drum |
International express |
1~3 days after your payment |
| 100-200kg |
25kg/drum,use two layer PP bag,then into cardboard drum |
Air shipping Sea Shipping |
3~5 days after your payment |
| Over 500kg |
25kg/drum,use two layer PP bag,then into cardboard drum |
Sea shipping |
5~10 days after your payment |
Q1: Can I get some free sample?
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}